Eli Lilly’s Mounjaro, Zepbound Drive $12.8 Billion in Q1 Revenue
The weight-loss and diabetes drugs accounted for nearly two-thirds of Lilly's $19.8 billion quarterly revenue, accelerating growth. Eli Lilly's Mounjaro and Zepbound generated $12.8 billion in revenue during Q1 2026, representing nearly 65% of the company's $19.8 billion t